Bispecific antibodies for viral immunotherapy by Elisabeth K. Nyakatura, Alexandra Y. Soare, Jonathan R. Lai

Subjects: Get full text

Vascular Normalization and Cancer Immunotherapy by Junli ZENG, Dongmei YUAN, Hongbing LIU, Yong SONG

Subjects: Get full text

Immunotherapy in older patients with cancer by C. Granier, A. Gey, S. Roncelin, L. Weiss, E. Paillaud, E. Tartour

Subjects: Get full text

The Potential of Exosomes in Allergy Immunotherapy by Paul Engeroff, Monique Vogel

“…The lack of disease-modifying therapies besides specific allergen immunotherapy (AIT) which is not available for all types of allergies, necessitates the study of novel therapeutic approaches. …”
Get full text

Pleural Mesothelioma in the Era of Immunotherapy by Mathieu Chevallier, Floryane Kim, Alex Friedlaender, Alfredo Addeo

“…Over the course of the last decade, immunotherapy has revolutionised the management of a great number of cancer types. …”
Get full text

Immunotherapy in oral cancer: Review by Papaioannou Despoina, Petsali Spyridoula, Ndreou Alida, Akritidou Fani, Zisis Vasileios, Kavvadas Dimitrios, Poulopoulos Athanasios, Karachrysafi Sofia, Andreadis Dimitrios

Subjects: “…immunotherapy…”
Get full text

The Role of Immunotherapy in Multiple Myeloma by Mehmet Kocoglu, Ashraf Badros

Subjects: Get full text

Immunotherapies for advanced hepatocellular carcinoma by Li-Yang Sun, Li-Yang Sun, Kang-Jun Zhang, Kang-Jun Zhang, Ya-Ming Xie, Jun-Wei Liu, Zun-Qiang Xiao

Subjects: Get full text

The State of Immunotherapy in Hepatobiliary Cancers by Farhan Z. Ilyas, Joal D. Beane, Timothy M. Pawlik

Subjects: Get full text

Immunotherapy in Opioid Use Disorders by Hakan Aksu, Bahadır Geniş, Zehra Arıkan

Subjects: Get full text

T-cell agonists in cancer immunotherapy by Gennaro Ciliberto, Aung Naing, Joud Hajjar, Cara L Haymaker, Yeonjoo Choi, Yaoyao Shi

“…Journal for ImmunoTherapy of Cancer…”
Get full text

IMMUNOTHERAPY IN THE TREATMENT OF RECURRENT RHINOSINUSITIS by Irina Veniaminovna Stagnieva

“…To correct the immune deficiency in the standard treatment of purulent rhinosinusitis scheme in some patients with the level of SP <100 pg / mL (n = 30) on the first day included immunotherapy. The control group (n = 24) was treated in the normal way – without immunomodulator. …”
Get full text

Role of the immunosuppressive microenvironment in immunotherapy by Garth W. Tormoen, MD, PhD, Marka R. Crittenden, MD, PhD, Michael J. Gough, PhD

“…Immunotherapy is reshaping cancer treatment paradigms; however, response rates to immune therapies are low and depend on the host's pre-existing antitumor immunity. …”
Get full text

Immunotherapy for Renal Cell Carcinoma by Momoe Itsumi, Katsunori Tatsugami

“…The authors outline the principles of cell-mediated tumor immunotherapy and discuss clinical trials of immunotherapy for RCC.…”
Get full text

Biomarkers for immunotherapy for treatment of glioblastoma by John P Lynes, Anthony K Nwankwo, Hannah P Sur, Victoria E Sanchez, Kwadwo A Sarpong, Oluwatobi I Ariyo, Gifty A Dominah, Edjah K Nduom

“…Journal for ImmunoTherapy of Cancer…”
Get full text

Progresses in biomarkers for cancer immunotherapy by Xuwen Lin, Chenyu Zong, Zhihan Zhang, Weiyi Fang, Ping Xu

Subjects: Get full text

Immunotherapies: The Blockade of Inhibitory Signals by Yan-Ling Wu, Jing Liang, Wen Zhang, Yoshimasa Tanaka, Hiroshi Sugiyama

“…The inhibitory receptors such as CTLA-4, PD-1, and BTLA have recently drawn much attention as potential targets for immunotherapies. This review focuses on the progress that has been made with the mentioned receptors in the field of immunotherapies for autoimmune diseases, malignancies, infectious diseases, and transplantation.…”
Get full text

Bispecific antibodies in cancer immunotherapy by Eva Dahlén, Niina Veitonmäki, Per Norlén

“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text

Inhibiting VEGF in cancer immunotherapy by Masahiko Shibata, Koji Kono, Seiichi Takenoshita

Subjects: Get full text

Magnetic systems for cancer immunotherapy by Nicole B. Day, William C. Wixson, C. Wyatt Shields, IV

Subjects: Get full text